Benjamin Nagy



FDA takes steps to automate drug registration; Plan B OTC availability still an area of contention

September 01, 2006

FDA issued a proposed rule late last month that would allow pharmaceutical manufacturers to register and list products electronically in an effort to minimize the paper-based element of the process, allowing the agency to host a comprehensive national database of medications and to be more flexible in its role of monitoring the safety of medications for sale, according to officials.